BLLN
BillionToOne, Inc. - Class A common stock (BLLN)
$42
About BillionToOne, Inc. - Class A common stock (BLLN)
BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. Its patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. The was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.
Details
Daily high
$117.19
Daily low
$113.55
Price at open
$116.00
52 Week High
$150.44
52 Week Low
$60.00
Market cap
5.5B
Dividend yield
-
Volume
3,277
Avg. volume
632,068
P/E ratio
188.39
BillionToOne, Inc. - Class A common stock News
Details
Daily high
$117.19
Daily low
$113.55
Price at open
$116.00
52 Week High
$150.44
52 Week Low
$60.00
Market cap
5.5B
Dividend yield
-
Volume
3,277
Avg. volume
632,068
P/E ratio
188.39